SCHEMBL25333374

SCHEMBL25333374

N[C@H](C=O)N1CCc2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.43
SLC6A4 P31645 2/20 0.43
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ALDH1A1 P00352 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
USP2 O75604 1/20 0.42
CDK4 P11802 1/20 0.42
ALOX15 P16050 1/20 0.42
CCND1 P24385 1/20 0.42
GAA P10253 4/20 0.41
GFER P55789 1/20 0.41
NOTUM Q6P988 1/20 0.41
TP53 P04637 3/20 0.41
MAPT P10636 2/20 0.41
TSHR P16473 2/20 0.40
LMNA P02545 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL463221 0.83 SLC6A2 (0.42) SLC6A2SLC6A4NPC1RAB9AALDH1A1
SCHEMBL19953534 0.79 MEN1 (0.42) SLC6A2SLC6A4NPC1RAB9AALDH1A1
SCHEMBL27675115 0.79 NOTUM (0.45) SLC6A2SLC6A4L3MBTL1ALDH1A1MEN1
SCHEMBL27463313 0.79 ALDH1A1 (0.42) SLC6A2SLC6A4NPC1RAB9AALDH1A1
SCHEMBL307372 0.79 NOTUM (0.45) NPC1RAB9AL3MBTL1ALDH1A1MEN1
SCHEMBL28292118 0.77 MAPT (0.48) SLC6A2SLC6A4NPC1RAB9AL3MBTL1
SCHEMBL11852260 0.77 GAA (0.47) SLC6A2SLC6A4ALDH1A1MEN1KMT2A
SCHEMBL25112007 0.77 SLC6A2 (0.49) SLC6A2SLC6A4NPC1RAB9AL3MBTL1
SCHEMBL23723712 0.76 SLC6A2 (0.46) SLC6A2SLC6A4NPC1RAB9AALDH1A1
SCHEMBL534412 0.74 SLC6A2 (0.50) SLC6A2SLC6A4NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023144793-A1 POL THETA INHIBITORS RHIZEN PHARMACEUTICALS AG (CH) 2023-08-03 WO disclosed